What is the recommended treatment for cat scratch fever?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Cat Scratch Fever

Azithromycin is the recommended first-line treatment for cat scratch disease, with a dosing protocol of 500 mg on day 1 followed by 250 mg for 4 additional days for patients >45 kg, or 10 mg/kg on day 1 and 5 mg/kg for 4 more days for patients <45 kg. 1

Clinical Presentation and Diagnosis

Cat scratch disease (CSD) is caused by Bartonella henselae, a fastidious gram-negative bacillus transmitted through cat scratches or bites. The clinical presentation typically includes:

  • A papule or pustule developing 3-30 days after a scratch or bite 1
  • Regional lymphadenopathy occurring approximately 3 weeks after inoculation 1
  • Lymphadenopathy generally resolving within 1-6 months, with suppuration in about 10% of cases 1
  • Extranodal disease (affecting CNS, liver, spleen, bone, lung) developing in ≤2% of cases 1

Diagnosis is typically based on:

  • History of cat exposure 2
  • Serologic testing with high titers (>1:256) of IgG antibody to B. henselae 2
  • PCR or Warthin-Starry silver stain of infected lymph node tissue in difficult cases 1

Treatment Algorithm

Immunocompetent Patients with Typical CSD

  1. First-line treatment: Azithromycin

    • Adults >45 kg: 500 mg on day 1, then 250 mg daily for 4 days 1
    • Children <45 kg: 10 mg/kg on day 1, then 5 mg/kg daily for 4 days 1
  2. Alternative treatments (if azithromycin is contraindicated):

    • Doxycycline 100 mg twice daily 1
    • Erythromycin 500 mg four times daily 1
    • Ciprofloxacin 500 mg twice daily 3
    • Trimethoprim-sulfamethoxazole 4

Immunocompromised Patients with Bacillary Angiomatosis

For immunocompromised patients (especially those with HIV/AIDS) who develop bacillary angiomatosis:

  • First-line treatment: Erythromycin 500 mg four times daily or doxycycline 100 mg twice daily for 2 weeks to 2 months 1
  • Alternative treatment: Clarithromycin or azithromycin 1
  • Duration: Therapy should be administered for >3 months 1
  • For CNS involvement: Doxycycline with or without rifampin 1

Prevention of Recurrence

  • Long-term suppression with erythromycin or doxycycline should be considered for patients with relapse or reinfection 1
  • For pregnant women requiring long-term suppression, erythromycin should be used (tetracyclines are contraindicated during pregnancy) 1

Evidence Quality and Treatment Efficacy

The recommendation for azithromycin is based on a placebo-controlled study showing more rapid reduction in lymph node size (80% regression at 30 days) in patients receiving azithromycin compared to placebo (P = .02) 1. This represents the strongest evidence available for treatment efficacy.

Most cases of cat scratch disease in immunocompetent hosts are self-limited and may not require antibiotic therapy 4, 2. However, treatment is recommended for:

  • Severe or persistent cases 5
  • Patients with systemic symptoms 2
  • Immunocompromised patients 1
  • Cases with extranodal or disseminated disease 1

Prevention Measures

For prevention of Bartonella infection, especially in immunocompromised individuals:

  • Consider risks of cat ownership, particularly for severely immunosuppressed persons 1
  • If acquiring a cat, choose one >1 year old in good health 1
  • Avoid rough play with cats and situations where scratches are likely 1
  • Promptly wash any cat-associated wounds 1
  • Implement comprehensive flea control for cats 1
  • Do not allow cats to lick open wounds 1

Special Considerations

  • Children: The same treatment recommendations apply, with weight-based dosing for azithromycin 1
  • Pregnant women: Erythromycin is preferred; tetracyclines should be avoided 1
  • HIV-infected patients: More aggressive and prolonged treatment is needed, particularly for bacillary angiomatosis 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cat-scratch Disease.

American family physician, 2011

Research

Treatment of cat-scratch disease.

Current opinion in pediatrics, 2001

Research

Cat-scratch disease and related clinical syndromes.

American family physician, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.